159 related articles for article (PubMed ID: 21130414)
1. Is there a role for differentiating therapy in non-APL AML?
Koeffler HP
Best Pract Res Clin Haematol; 2010 Dec; 23(4):503-8. PubMed ID: 21130414
[TBL] [Abstract][Full Text] [Related]
2. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
[No Abstract] [Full Text] [Related]
3. CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.
Truong BT; Lee YJ; Lodie TA; Park DJ; Perrotti D; Watanabe N; Koeffler HP; Nakajima H; Tenen DG; Kogan SC
Blood; 2003 Feb; 101(3):1141-8. PubMed ID: 12393450
[TBL] [Abstract][Full Text] [Related]
4. Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation.
van Gils N; Verhagen HJMP; Smit L
Exp Hematol; 2017 Aug; 52():12-23. PubMed ID: 28456748
[TBL] [Abstract][Full Text] [Related]
5. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
[TBL] [Abstract][Full Text] [Related]
6. AML bearing the translocation t(11;17)(q23;q21): involvement of MLL and a region close to RARA, with no differentiation response to retinoic acid.
Classen CF; Teigler-Schlegel A; Röttgers S; Reinhardt D; Döhner K; Debatin KM
Ann Hematol; 2005 Nov; 84(12):774-80. PubMed ID: 16044313
[TBL] [Abstract][Full Text] [Related]
7. The c-Myc-regulated miR-17-92 cluster mediates ATRA-induced APL cell differentiation.
Yu X; Hu Y; Wu Y; Fang C; Lai J; Chen S; Li Y; Zeng C; Zeng Y
Asia Pac J Clin Oncol; 2019 Dec; 15(6):364-370. PubMed ID: 31264378
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
Zeng C; Yu X; Lai J; Yang L; Chen S; Li Y
J Hematol Oncol; 2015 Nov; 8():126. PubMed ID: 26545364
[TBL] [Abstract][Full Text] [Related]
9. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells.
Misra S; Selvam AK; Wallenberg M; Ambati A; Matolcsy A; Magalhaes I; Lauter G; Björnstedt M
Oncotarget; 2016 Nov; 7(46):74686-74700. PubMed ID: 27732960
[TBL] [Abstract][Full Text] [Related]
10. All-trans retinoic acid (ATRA)-induced TFEB expression is required for myeloid differentiation in acute promyelocytic leukemia (APL).
Orfali N; O'Donovan TR; Cahill MR; Benjamin D; Nanus DM; McKenna SL; Gudas LJ; Mongan NP
Eur J Haematol; 2020 Mar; 104(3):236-250. PubMed ID: 31811682
[TBL] [Abstract][Full Text] [Related]
11. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
12. CEBPA-regulated lncRNAs, new players in the study of acute myeloid leukemia.
Hughes JM; Salvatori B; Giorgi FM; Bozzoni I; Fatica A
J Hematol Oncol; 2014 Sep; 7():69. PubMed ID: 25252716
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
14. p38αMAPK interacts with and inhibits RARα: suppression of the kinase enhances the therapeutic activity of retinoids in acute myeloid leukemia cells.
Gianni M; Peviani M; Bruck N; Rambaldi A; Borleri G; Terao M; Kurosaki M; Paroni G; Rochette-Egly C; Garattini E
Leukemia; 2012 Aug; 26(8):1850-61. PubMed ID: 22354283
[TBL] [Abstract][Full Text] [Related]
15. Transglutaminase 2 programs differentiating acute promyelocytic leukemia cells in all-trans retinoic acid treatment to inflammatory stage through NF-κB activation.
Jambrovics K; Uray IP; Keresztessy Z; Keillor JW; Fésüs L; Balajthy Z
Haematologica; 2019 Mar; 104(3):505-515. PubMed ID: 30237268
[TBL] [Abstract][Full Text] [Related]
16. CDK2 suppression synergizes with all-trans-retinoic acid to overcome the myeloid differentiation blockade of AML cells.
Shao X; Xiang S; Fu H; Chen Y; Xu A; Liu Y; Qi X; Cao J; Zhu H; Yang B; He Q; Ying M
Pharmacol Res; 2020 Jan; 151():104545. PubMed ID: 31740384
[TBL] [Abstract][Full Text] [Related]
17. Combination of retinoic acid and tumor necrosis factor overcomes the maturation block in a variety of retinoic acid-resistant acute promyelocytic leukemia cells.
Witcher M; Shiu HY; Guo Q; Miller WH
Blood; 2004 Nov; 104(10):3335-42. PubMed ID: 15256426
[TBL] [Abstract][Full Text] [Related]
18. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
Niitsu N; Higashihara M; Honma Y
Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
[TBL] [Abstract][Full Text] [Related]
19. All-trans-retinoic acid induces CD52 expression in acute promyelocytic leukemia.
Li SW; Tang D; Ahrens KP; She JX; Braylan RC; Yang L
Blood; 2003 Mar; 101(5):1977-80. PubMed ID: 12393392
[TBL] [Abstract][Full Text] [Related]
20. Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation.
Ravasio R; Ceccacci E; Nicosia L; Hosseini A; Rossi PL; Barozzi I; Fornasari L; Zuffo RD; Valente S; Fioravanti R; Mercurio C; Varasi M; Mattevi A; Mai A; Pavesi G; Bonaldi T; Minucci S
Sci Adv; 2020 Apr; 6(15):eaax2746. PubMed ID: 32284990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
